Towards deciphering the functional genetics and neo-antigenic landscape in melanoma
18 Jul 2016
Towards deciphering the functional genetics and neo-antigenic landscape in melanoma
Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?
Polycomb repressors and epigenetic therapy
DNA repair and mutations as targets for personalised therapy
The changing process of drug discovery and design
Glioblastoma heterogeneity in circulating tumour DNA
Obesity promotes pancreatic cancer progression and resistance
Connections in cancer-host immune signalling
Targeting and imaging invasion and metastasis
ERß expression predicts breast cancer risk in hyperplasia
Advances in early detection
Polygenic risk and the targeted prevention of cancer